DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Methylthioninium is an investigational drug.
There have been 5 clinical trials for Methylthioninium. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2016.
The most common disease conditions in clinical trials are Adenocarcinoma, Dysuria, and Breast Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), I.M. Sechenov First Moscow State Medical University, and Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS).
There are thirty-two US patents protecting this investigational drug and seven hundred and eleven international patents.
Recent Clinical Trials for Methylthioninium
|COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy||Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS)||Phase 1|
|COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy||I.M. Sechenov First Moscow State Medical University||Phase 1|
|Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria||EMS||Phase 3|
Top disease conditions for Methylthioninium
Top clinical trial sponsors for Methylthioninium
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Methylthioninium||⤷ Try it Free||Anti-Tau antibodies and methods of use||Genentech, Inc. (South San Francisco, CA) AC Immune SA (Lausanne, CH)||⤷ Try it Free|
|Methylthioninium||⤷ Try it Free||Humanized tau antibodies in a alzheimer's disease||Axon Neuroscience SE (Larnaka, CY)||⤷ Try it Free|
|Methylthioninium||⤷ Try it Free||Anti-Tau Antibodies and methods of use||Genentech, Inc. (South San Francisco, CA) AC Immune SA (Lausanne, CH)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Methylthioninium||Argentina||AR104875||2035-06-05||⤷ Try it Free|
|Methylthioninium||Australia||AU2016270858||2035-06-05||⤷ Try it Free|
|Methylthioninium||Canada||CA2986942||2035-06-05||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|